SMARCA4: Current status and future perspectives in non-small-cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference155 articles.
1. The effect of advances in lung-cancer treatment on population mortality;Howlader;N. Engl. J. Med.,2020
2. First-line immunotherapy for non-small-cell lung cancer;Reck;J. Clin. Oncol.,2022
3. Clinically-meaningful improvements in therapy for unresectable NSCLC;Katakura;Expert Rev. Anticancer Ther.,2022
4. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs;Kris;JAMA,2014
5. Targeted therapies for lung cancer patients with oncogenic driver molecular alterations;Tan;J. Clin. Oncol.,2022
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. First description of a primary SMARCA4-deficient carcinoma of the salivary glands;Human Pathology Reports;2024-11
2. Strategies for enhancing non-small cell lung cancer treatment: Integrating Chinese herbal medicines with epidermal growth factor receptor-tyrosine kinase inhibitors therapy;European Journal of Pharmacology;2024-10
3. Re-analysis of single cell and spatial transcriptomics data reveals B cell landscape in gastric cancer microenvironment and its potential crosstalk with tumor cells for clinical prognosis;Journal of Translational Medicine;2024-08-30
4. SMARCA4-deficient undifferentiated tumor with high quality of life and far exceeding predicted survival: A case report;Medicine;2024-08-02
5. New promises and challenges in the treatment of advanced non-small-cell lung cancer;The Lancet;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3